NCT06582849 Enhanced Assistance During Radiotherapy for Unmet Essential Needs Status COMPLETED Phase NA
NCT06573151 Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL Status NOT_YET_RECRUITING Phase PHASE2
NCT06563505 A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma Status RECRUITING Phase PHASE2
NCT06558513 To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT06557330 MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06550427 Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing Status RECRUITING Phase N/A
NCT06522737 A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype Status RECRUITING Phase PHASE3
NCT06510361 Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy Status RECRUITING Phase PHASE2
NCT06510309 Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma Status RECRUITING Phase PHASE2
NCT06441331 Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors Status RECRUITING Phase PHASE1
NCT06430736 PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) Status RECRUITING Phase PHASE2
NCT06409767 Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation. Status RECRUITING Phase NA
NCT06398457 Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies Status RECRUITING Phase EARLY_PHASE1